Ernexa Therapeutics Inc.
13F holders, Q2 2024 (June 30)20holders −3
2new positions
5sold out
$1.83avg. 13F price*
At the end of Q2 2024, 20 institutions reported holding Ernexa Therapeutics Inc. in their 13F filings, down 3 from Q1 2024. 2 opened new positions and 5 sold out. The largest holders were Cypress Point Wealth Management, LLC ($173K), Naviter Wealth, LLC ($144K) and Sippican Capital Advisors ($133K).
- Company
- Ernexa Therapeutics Inc.
- Filed as
- ETERNA THERAPEUTICS INC (Q2 2024)
- CUSIP
- 114082209
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $145 |
| Exits | 5 | $51K |
All 13F filers, Q1 2024 → Q2 2024: 2,472 shares bought and 21,599 shares sold, net −19,127 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Cypress Point Wealth Management, LLC | 0.08% | No change | 94,375 | $173K |
| Naviter Wealth, LLC | 0.02% | No change | 78,796 | $144K |
| Sippican Capital Advisors | 0.11% | No change | 72,800 | $133K |
| Corient Private Wealth LP | 0.00% | No change | 50,398 | $91K |
| Vanguard Group Inc. | 0.00% | No change | 26,099 | $48K |
| Geode Capital Management, LLC | 0.00% | Add +5.5% | 23,719 | $43K |
| BlackRock Inc. | 0.00% | Reduce -4.1% | 14,973 | $27K |
| Avidian Wealth Enterprises, LLC | 0.00% | No change | 14,798 | $27K |
| Baldwin Wealth Partners LLC | 0.00% | No change | 8,544 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +26.7% | 5,174 | $9K |
| Montag A & Associates Inc. | 0.00% | Add +50.4% | 212 | $388 |
| Morgan Stanley | 0.00% | No change | 50 | $92 |
| Activest Wealth Management | 0.00% | New | 50 | $92 |
| Bank of America Corp. | 0.00% | New | 29 | $53 |
| Group One Trading LLC | 0.00% | No change | 19 | $34 |
| Citigroup Inc. | 0.00% | No change | 15 | $27 |
| JPMorgan Chase & Co. | 0.00% | No change | 14 | $25 |
| Aspire Private Capital, LLC | 0.00% | No change | 10 | $18 |
| Qube Research & Technologies Ltd | 0.00% | No change | 4 | $8 |
| Royal Bank of Canada | 0.00% | No change | 22 | $0 |
"% of holder's portfolio" is ERNEXA THERAPEUTICS INC's weight in each manager's 13F, not the share of Ernexa Therapeutics Inc. the manager owns.